Medical Countermeasures Appili Therapeutics Reports Strong Preclinical Protection from ATI-1701 Tularemia VaccineGlobal Biodefense StaffAugust 11, 2025
Medical Countermeasures Pan-Coronavirus Drug Discovery Gets a Boost from Global AI Blind ChallengeGlobal Biodefense StaffJuly 28, 2025
Glaxo Teams with Texas A&M for Influenza Manufacturing Center of Excellence Industry News April 5, 2013 …
Study of Virus-Killing Bacteria Motion Advances Nanotechnology Medical Countermeasures April 1, 2013 …
U.S. Army Hantavirus Vaccine Support Contract to Althea Technologies Defense + Military April 1, 2013 …
Government Building ‘Fill and Finish’ Network for Pandemic Influenza Vaccines Contracts + Grants April 1, 2013 …
Drug Target Development Proposals Sought for Antimicrobial-Resistant Pathogens Antimicrobial Resistance March 27, 2013 …
Study Reveals Potential Treatments for Ebola and Other Deadly Viruses Medical Countermeasures March 26, 2013 …
USF Researchers Play Key Role in Discovery of New Drug to Combat Malaria Medical Countermeasures March 25, 2013 …
FDA Approves First Antitoxin to Neutralize All 7 Botulism Serotypes Medical Countermeasures March 25, 2013 …
Nanotherapeutics Awarded $135M for Medical Countermeasures Advanced Development Defense + Military March 23, 2013 …
Anthrax Vaccine Trial for Kids? The Ethics of Pediatric Countermeasures Research Medical Countermeasures March 19, 2013 …
